Washington Trust CO Biogen Inc. Transaction History

Washington Trust CO

$2.76 Billion
Q4 2024

A detailed history of Washington Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Washington Trust CO holds 312 shares of BIIB stock, worth $37,209. This represents 0.0% of its overall portfolio holdings.

Number of Shares

312

Previous 312 -0.0%

Holding current value

$37,209

Previous $60,000 21.67%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $80,046 - $91,210	312 New	312 $86,000
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $80,046 - $91,210	-312 Closed	0 $87,000
Q1 2022 May 05, 2022	SELL	$193.77 - $244.14 $2,906 - $3,662	-15 Reduced 4.59%	312 $66,000
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $22,839 - $29,352	-102 Reduced 23.78%	327 $78,000
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $565 - $738	2 Added 0.47%	429 $121,000
Q2 2021 Aug 05, 2021	BUY	$259.0 - $414.71 $76,923 - $123,168	297 Added 228.46%	427 $148,000
Q1 2021 Apr 28, 2021	BUY	$242.95 - $284.63 $4,859 - $5,692	20 Added 18.18%	130 $36,000
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $14,175 - $21,337	60 Added 120.0%	110 $27,000
Q3 2020 Nov 05, 2020	BUY	$264.77 - $305.71 $9,266 - $10,699	35 Added 233.33%	50 $14,000
Q2 2020 Aug 04, 2020	SELL	$258.66 - $342.55 $3,879 - $5,138	-15 Reduced 50.0%	15 $4,000
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $8,065 - $10,231	30 New	30 $10,000
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $74,845 - $97,876	-255 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $65,667 - $78,262	255 New	255 $74,000

Others Institutions Holding BIIB

# of Institutions

1,012

Shares Held

126M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Biogen Inc. Transaction History